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Obesity and the metabolic syndrome have reached epidemic proportions worldwide with
far-reaching health care and economic implications.The rapid increase in the prevalence of
these disorders suggests that environmental and behavioral influences, rather than genetic
causes, are fueling the epidemic.The developmental origins of health and disease hypoth-
esis has highlighted the link between the periconceptual, fetal, and early infant phases of
life and the subsequent development of metabolic disorders in later life. In particular, the
impact of poor maternal nutrition on susceptibility to later life metabolic disease in offspring
is now well documented. Several studies have now shown, at least in experimental animal
models, that some components of the metabolic syndrome, induced as a consequence
of developmental programming, are potentially reversible by nutritional or targeted ther-
apeutic interventions during windows of developmental plasticity. This review will focus
on critical windows of development and possible therapeutic avenues that may reduce
metabolic and obesogenic risk following an adverse early life environment.
Keywords: developmental programming, obesity, metabolic syndrome, maternal nutrition, leptin, insulin resis-
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INTRODUCTION
Obesity is a serious health issue in the developed world and is
becoming increasingly important on a global scale. Multiple sys-
tems regulate energy homeostasis and there is strong evidence for
a genetic component to human obesity as a number of genes asso-
ciated with human obesity have been identified (Hofbauer, 2002;
Bell et al., 2005). However, a genetic component to obesity can-
not account for the dramatic increase in the prevalence of obesity
in recent years. It is a widely held view that the primary cause
of obesity and related metabolic disorders in the general popula-
tion is due to the ease of access to highly calorific food and reduced
energy expenditure in work and leisure activities (Bell et al., 2005).
However, it is now well established that events that occur during
critical developmental windows influence obesity risk with epi-
demiological, experimental, and clinical data showing that the
risk of developing disease in later life is dependent upon early
life conditions. In particular, altered maternal nutrition, including
undernutrition and overnutrition, can lead to metabolic disorders
Abbreviations: ARH, arcuate nucleus of the hypothalamus; BBB, blood brain
barrier; DEX, dexamethasone; Fas, fatty acid synthase; Flk-1, vascular endothe-
lial growth factor receptor 2; GH, growth hormone; GLP-1, glucagon-like pep-
tide 1; IGF-I, insulin-like growth factor I; IGF-II, insulin-like growth factor II;
IUGR, intrauterine growth restriction; MLP, maternal low protein; PARs, predic-
tive adaptive responses; PDX1, pancreatic and duodenal homeobox 1; PGC-1,
peroxisome-proliferator-activated receptor-gamma co-activator-1; PPAR, peroxi-
some proliferator-activated receptor; SGA, small for gestational age; SL, small litter;
SOCS-3, suppressor of cytokine signaling-3; STAT-3, signal transducer and activator
of transcription 3; UN, undernutrition; VAT, visceral adipose tissue; VEGF, vascular
endothelial growth factor; WAT, white adipose tissue.
in offspring characterized by obesity and leptin resistance (Ravelli
et al., 1999; Godfrey and Barker, 2000; Breier et al., 2001). The
mechanisms underlying such associations and the relative role of
genetic versus environmental factors however, remain speculative.
Adaptive responses made by a fetus to an adverse intrauterine
environment results in new physiological set points aimed at max-
imizing immediate chances for survival. These adaptations may
include resetting of metabolic homeostasis and endocrine systems
and the down-regulation of growth which is commonly reflected
in an altered birth phenotype. The “predictive adaptive response”
(PAR) hypothesis proposes that the degree of mismatch between
the pre- and postnatal environment is a major determinant of sub-
sequent disease (Gluckman and Hanson, 2004a; Gluckman et al.,
2008). Thus, it is thought that whilst adaptive changes in fetal
physiological function may be beneficial for short term survival
in utero, these changes may be maladaptive in postnatal life and
contribute to poor health outcomes particularly when offspring
are exposed to catch-up growth, diet-induced obesity and other
environmental factors (Gluckman and Hanson, 2004b; Gluckman
et al., 2008). These so-called PARs are therefore proposed to be not
merely side-effects of growth restriction in utero, but are a strat-
egy designed to optimize the physiology of the offspring for the
postnatal environment it is most likely to experience, that is, the
“predicted” environment.
DEVELOPMENTAL PROGRAMMING OF OBESITY AND
METABOLIC DISORDERS – EVIDENCE FROM EPIDEMIOLOGY
Barker and colleagues demonstrated a relationship between low
birth weight and an increased risk of hypertension, obesity, insulin
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resistance, and dyslipidemia in later life (Barker et al., 1989, 1990;
Osmond et al., 1990). From these initial observations, the impor-
tance of maternal nutrition and, in particular the effect of poor
maternal nutrition on birth weight and adult disease risk was
addressed in human studies of famine exposure. The most widely
reported of these being the Dutch Hunger Winter of 1944–1945
(Ravelli et al., 1976, 1999; Roseboom et al., 1999, 2001); demon-
strating that the timing of the exposure was a major determinant
in phenotypic outcomes. Whereas famine exposure during early
gestation was associated with adult hypertension (Ravelli et al.,
1976), reduced maternal famine during late gestation was asso-
ciated with an increased adult adiposity and glucose intolerance
(Law et al., 1992; Ravelli et al., 1999). Famine exposure late in
pregnancy led to a greater impairment of glucose tolerance than
during early or mid-gestation. The rate of obesity was higher in
men exposed in the first half of gestation and lower in men exposed
in the last trimester of gestation as compared to non-exposed men.
These relationships however do not speak to causation and other
reports of prenatal famine exposure have yielded contradictory
results. Retrospective studies investigating offspring exposed to
famine during the siege of Leningrad did not show any relationship
between birthweight and adult metabolic sequelae (Stanner and
Yudkin, 2001). The disparity between the Dutch and the Leningrad
studies may be explained using the PARs framework. Following
the short period of the Dutch Winter Hunger, food supply was
returned to normal levels and maternal nutrition restored; thus
in many pregnancies fetuses would have been acutely “starved”
in utero and subsequently well nourished in postnatal life. This
may represent a circumstance that the PARs hypothesis may would
describe as a nutritional mismatch between the intrauterine and
postnatal – the actual and the predicted – environments. Con-
versely, in the Leningrad cohort, maternal nutritional status was
poor both before and after pregnancy and thus one can specu-
late that any fetal adaptations may have been appropriate for the
predicted postnatal environment.
In historically undernourished, recently urbanized populations
such as India, where low birth weight individuals are exposed to
a high-fat Western diet, the incidence of obesity and type 2 dia-
betes is reaching epidemic proportions (Yajnik, 2000). Work by
Yajnik and colleagues have shown that although Indian babies
are born low birth weight, they exhibit increased visceral adipos-
ity (Yajnik, 2000). This is consistent with other studies, that have
demonstrated in small babies a disproportionate abdominal fat
mass during adult life, despite a lower body mass index (BMI;
McMillen et al., 2005). Although there is considerable debate
regarding whether accelerated postnatal growth after fetal growth
restriction (catch-up growth) in early postnatal life is beneficial
or not, most studies suggested that postnatal “catch-up” growth is
associated with adverse outcomes in later life (Eriksson et al., 1999;
Ong et al., 2000). Interestingly, work by Parsons et al. (2001) found
that men with a lower birth weight, who then exhibited catch-up
growth to achieve a greater proportion of their adult height by age
7, had a risk of obesity comparable to that of men with higher
birth weights. Work by Eriksson et al. (2003) has demonstrated
that ponderal index at birth was a reliable predictor of later obe-
sity and also found that an early adiposity rebound in babies born
of low birth weight was associated with obesity in adult life.
DEVELOPMENTAL PROGRAMMING OF OBESITY – EVIDENCE
FROM ANIMAL STUDIES
Animal models have been extensively used to provide empirical
data to support the developmental origins of health and disease
(DOHaD) hypothesis and essential to the search for the mechanis-
tic links between early life influences and disease risk in later life.
Although epidemiological data suggest that developmental pro-
gramming occurs within the normal range of birth size (Barker,
2007a,b), most experimental models tend to significantly restrict
fetal growth; in the past there was an assumption that those insults
that impair fetal growth are likely to be those that trigger develop-
mental programming. Several approaches have been developed to
induce early growth restriction in animals in an attempt to eluci-
date the relationship between growth restriction and adult disease
risk, potentially providing a framework for investigating underly-
ing mechanisms. However, intrauterine growth restriction (IUGR)
is not essential to developmental programming,but is merely a sur-
rogate for evidence that fetal development may have been affected.
Fetal growth restriction is either present or absent in experimental
studies depending on the species used and the insult; impaired
adult metabolic function is consistent regardless of the presence
or absence of growth restriction. In the rat, obesity and meta-
bolic disorders have been induced in offspring by maternal global
undernutrition (Woodall et al., 1996a; Vickers et al., 2000, 2001,
2002; McArdle et al., 2006), maternal protein restriction (Langley-
Evans et al., 1999), maternal uterine artery ligation (Rajakumar
et al., 1998; Simmons et al., 2001), maternal synthetic glucocor-
ticoid treatment (Nyirenda et al., 1998), maternal anemia (Lewis
et al., 2001), or prenatal cytokine exposure (Dahlgren et al., 2001).
MATERNAL UNDERNUTRITION
The early work of Barker and colleagues highlighted fetal nutri-
tion as the primary factor driving the developmental origins of
adult disease. Within the laboratory, fetal undernutrition is most
commonly achieved through maternal dietary restriction during
pregnancy. At present, rodent models investigating the mechanistic
links between maternal undernutrition and adult disease risk gen-
erally utilize one of two dietary protocols; global undernutrition
or isocaloric low protein diets. The maternal low protein (MLP)
diet during pregnancy and lactation is one of the most extensively
utilized models of nutritional programming (Snoeck et al., 1990;
Langley and Jackson, 1994; Desai et al., 1996; Ozanne et al., 1999;
Petry et al., 2001). In this model, pregnant rats are fed ad libitum a
low protein diet containing 5–8% (w/w) protein (casein), generally
a little under half the protein content but equivalent in energy of a
control diet containing 18–20% (w/w) protein (Snoeck et al., 1990;
Langley-Evans, 2000). Offspring from protein-restricted mothers
are 15–20% lighter than controls at birth (Desai et al., 1996). Main-
tenance of a MLP diet during the period of lactation increases this
weight difference and permanently limits later growth. If MLP off-
spring are cross-fostered at birth to lactating mothers fed a control
diet, they exhibit rapid catch-up growth (Desai et al., 1996). This
catch-up growth appears to have a detrimental effect on life span,
which results in premature death that is associated with accelerated
loss of kidney telomeric DNA (Jennings et al., 1999).
The experimental observations made in the MLP diet model
point toward a number of potential mechanisms that may underlie
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the pathogenesis of obesity and diabetes in these offspring; includ-
ing both structural and functional changes to a number of organ
and endocrine systems. Gene ontogeny analysis of visceral adi-
pose tissue (VAT) demonstrated a global up-regulation of genes
involved in carbohydrate, lipid, and protein metabolism in off-
spring of MLP animals; indicative of dynamic changes in the
transcriptional profile of key metabolic genes. These observations
are limited by the fact that a MLP diet is isocaloric compared to
the normal protein control diet and therefore by default contains
an increased fat and carbohydrate content because of passive over-
consumption on the MLP diet to reach protein targets (Sorensen
et al., 2008).
Global maternal undernutrition models have been developed
with a number of different levels of undernutrition during dif-
ferent periods of pregnancy. In the rat, moderate nutritional
restriction (70% of normal intake) in the first 18 days of pregnancy
resulted in offspring with significant IUGR, but offspring body
weight catches up to that of controls by postnatal day 20 (Ozaki
et al., 2000). These offspring displayed characteristics of insulin
and leptin resistance These abnormalities increase with age and
are most pronounced in male offspring (Ozaki et al., 2000) and the
postnatal phenotype is markedly exacerbated when the offspring
are fed a high-fat diet post-weaning. Consistent with the MLP
model, transcriptional profiling in the UN model demonstrated
that maternal undernutrition induced metabolic programming,
favoring fat as an energy source and resulted in mitochondrial dys-
function affecting postnatal hepatic function and subsequently, via
the resultant metabolic changes in other organs, leads to the evo-
lution of a phenotype similar to that of the metabolic syndrome
(Morris et al., 2009).
We have developed rodent models using global maternal under-
nutrition (UN) throughout pregnancy (Woodall et al., 1996b;
Vickers et al., 2000). When dams are fed 30% of ad libitum intake
throughout pregnancy, i.e., a severe level of UN, offspring birth-
weights and placental weights were 25–30% lower than offspring of
control fed mothers. These offspring display increased adiposity,
hypertension, hyperinsulinemia, hyperleptinemia, reduced loco-
motor activity, and hyperphagia in adult life (Vickers et al., 2000,
2003; Krechowec et al., 2006). When the degree of UN is reduced
to a more moderate level, i.e., 50% of ad.libitum, offspring still dis-
play a significant level of obesity in postnatal life. A reduction to
20% of ad libitum intake during early pregnancy results in hyper-
insulinemia, increased total caloric intake and changes in weight
gain in a sex-specific manner with males, but not females, showing
increased body weight gain (Palou et al., 2010; Garcia et al., 2011).
Of note, if pre-weaning catch-up growth in offspring is prevented
by maintaining the mothers on the restricted diet throughout lac-
tation, offspring do not develop an obese phenotype (Desai et al.,
2005; Howie et al., 2011). This is similar to the MLP model where
continuation of the LP diet into lactation prevents the develop-
ment of the metabolic phenotype, once again highlighting the
possible adverse consequences of catch-up growth (Desai et al.,
2005).
In addition to caloric and protein restriction models, specific
micronutrient deficiencies have also been investigated. The effect
of maternal iron deficiency results in several features of the meta-
bolic syndrome in offspring (Lewis et al., 2001, 2002). Work by
Gambling et al. (2003) has highlighted that the timing of iron sup-
plementation is critical in reversing the effects of maternal anemia
on the developing fetus and postnatal sequelae in offspring. These
data correlate well with human studies showing that iron supple-
mentation during pregnancy leads to a higher mean birth weight
and reduced incidence of low birth weight infants (Cogswell et al.,
2003). Maternal chromium restriction significantly increased body
weight and fat percentage, especially central adiposity, in both male
and female rat offspring (Padmavathi et al., 2010a,b). Maternal
magnesium restriction can predispose rat pups to insulin resis-
tance and glucose intolerance (Venu et al., 2005). Maternal total
vitamin restriction increases body fat content but not insulin resis-
tance in rat offspring up to 6 months of age (Venu et al., 2004).
Conversely, high multivitamin intake during pregnancy has been
shown to program the male offspring who go on to demonstrate
characteristics of the metabolic syndrome in adulthood, possibly
through its effects on central mechanisms of food intake control
(Szeto et al., 2008).
MATERNAL NUTRITION EXCESS
Epidemiological studies have demonstrated that fetal growth
restriction correlates with adult disease, implying that fetal nutri-
tional deprivation is a strong stimulus for programming (Armitage
et al., 2005). As such, experimental animal models were developed
using controlled maternal caloric intake or protein or macronutri-
ent deficiency. However, in many developed societies,maternal and
postnatal caloric intake is either sufficient or excessive. A number
of studies have shown that the relationship between birth weight
and obesity risk is not a simple inverse linear association but is
a U-shaped curve; a higher prevalence of adult obesity occurs in
individuals in low or high birth weight categories and this has
often been attributed to both low and high planes of maternal
nutrition (Armitage et al., 2005; McMillen et al., 2005; Samuels-
son et al., 2008; Howie et al., 2009; Morris and Chen, 2009). Indeed
in pregnancies which have been complicated by maternal diabetes,
gestational diabetes, or impaired glucose tolerance, offspring have
been shown to be at greater risk of developing obesity (Holemans
et al., 2004). There is a similarity in offspring phenotypes derived
from both ends of the maternal nutritional spectrum; offspring of
both under- and over-nourished mothers display common meta-
bolic derangements including obesity and insulin resistance. The
components of the maternal diabetic and/or obesogenic envi-
ronment that mediate the detrimental effects on hypothalamic
appetite control and consequently offspring health are not clearly
established. A common phenotypic outcome across a range of pro-
gramming models is resistance to leptin in adulthood resulting in
a loss of inhibition of food intake (Ozanne, 2011). However, there
has been less focus on whether leptin resistance develops during
the very early stages of life, at a time when leptin itself has no
effect on food intake, but may play a mechanistic role in metabolic
programming (Mistry et al., 1999; Glavas et al., 2010).
Maternal obesity in the rat has been shown to reprogram
hypothalamic appetite signaling pathways and leptin signaling
at birth (Morris and Chen, 2009). These hypothalamic changes,
together with lower leptin levels in offspring of obese mothers
may contribute to the lower expression of key appetite regula-
tors at birth, suggestive of altered fetal neuronal development in
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response to maternal obesity. These alterations may contribute to
eating disorders later in life. Activation of STAT-3 signifies leptin
sensitivity and recent work in female rats by Shin et al. (2012) has
shown that at birth, despite IUGR offspring being hypoleptinemic,
hypothalamic leptin signaling was activated as seen by enhanced
STAT-3. Further, it has been shown that offspring of high-fat fed
(HF) dams exhibit an alteration in hypothalamic leptin-dependent
STAT-3 phosphorylation, independent of the level of post-weaning
nutrition (Ferezou-Viala et al., 2007).
It is notable that evidence for the programming of obesity
and several other features of the metabolic syndrome from both
nutrient restriction (caloric, protein, iron) and fat-feeding studies,
suggest a possible commonality of mechanism (Armitage et al.,
2004).
CRITICAL WINDOWS FOR INTERVENTION
Until recently, developmental programming was seen to be an irre-
versible change in developmental trajectory, the consequences of
which had to be managed, e.g., obesity and Type 2 diabetes. Few
studies have addressed the possibility of reversibility or prevention
of the postnatal programmed phenotype.
The adipokine leptin has received significant interest as a
potential programming factor; alterations in the profile of lep-
tin in early life are associated with altered susceptibility to obe-
sity and metabolic disorders in adulthood. Maintenance of a
critical leptin concentration during early development facili-
tates the normal maturation of tissues and signaling pathways
involved in metabolic homeostasis. A period of relative hypo-
or hyperleptinemia during this window of development will
induce some of the metabolic adaptations which underlie the
developmental programming of appetite control and metabolic
function.
It has now been shown in a range of animal models and a num-
ber of species that perturbations in the profile of leptin in early
life are associated with altered susceptibility to obesity and meta-
bolic disorders in adulthood. It has been proposed that deficiencies
in leptin during critical windows of development could lead to a
hardwiring of obesity (Horvath and Bruning, 2006). Manipula-
tion of early life leptin concentrations in animal models using
exogenous leptin and/or leptin antagonists have clearly shown a
role for leptin in determining metabolic fate in later life (Vickers,
2007; Attig et al., 2008a). The source of leptin during this critical
developmental window may be varied and likely includes maternal
transplacental transfer of leptin, endogenous fetal leptin but may
also include milk leptin during lactation. Leptin in maternal milk
is likely an important factor in the maturation of organ systems
and feeding pathways in the neonate. Breast milk leptin correlates
positively with maternal plasma leptin concentrations although
the concentration in breast milk is significantly lower than that
found in maternal plasma (Ucar et al., 2000). Breast fed infants
have higher serum leptin levels compared to formula fed infants;
and formula fed infants may be at an increased risk of developing
obesity (Savino et al., 2009). Experimentally, oral intake of phys-
iological doses of leptin during lactation in rats has been shown
to prevent obesity in later life (Pico et al., 2007) supporting the
hypothesis that milk leptin plays a favorable role in developmental
programming.
In adult mammals, leptin acts on the brain to reduce food
intake by regulating the activity of neurons in the arcuate nucleus
(ARH). Bouret et al. have shown that neural projection pathways
from the ARH are permanently disrupted in leptin-deficient ob/ob
mice (Bouret and Simerly, 2004; Bouret et al., 2004a). Treatment
of ob/ob neonates with exogenous leptin rescues the development
of ARH projections, and leptin promotes neurite outgrowth from
ARH neurons in vitro. It is well established that small for ges-
tational age (SGA) neonates have diminished cord blood leptin
concentrations and as children are hypoleptinemic (Iniguez et al.,
2004). These children go on to develop obesity and leptin resis-
tance in adult life; which can be mimicked experimentally in the
rat (Vickers et al., 2000). Thus, perinatal nutritional perturbations
that alter leptin levels may have enduring consequences for the
formation and function of neuronal circuits that regulate food
intake and body weight (Elmquist et al., 1998; Bouret and Simerly,
2004; Bouret et al., 2004a,b). Leptin treatment to neonatal female
rats born to undernourished mothers prevented the development
of metabolic compromise in adulthood (Vickers et al., 2005). The
complete normalization of the programmed metabolic phenotype
by neonatal leptin treatment implied that leptin can reverse pre-
natal adaptations resulting from fetal undernutrition. Moreover,
the effects were specific to low birth weight animals, whilst lep-
tin had no effect in animals born to control mothers. Whether
this leptin effect acts centrally or peripherally is unclear – one
possibility is that the window of developmental plasticity is still
open and the high leptin levels reverse the cuing effects of pre-
natal undernutrition (Gluckman et al., 2007). Consistent with
this, neonatal leptin treatment to IUGR piglets partially reversed
the growth restricted phenotype by correcting growth rate, body
composition, and development of several organs involved in meta-
bolic regulation (Attig et al., 2008b). It has recently been reported
that intranasal leptin reduces appetite and induces weight loss
in rats with diet-induced obesity (Schulz et al., 2011) but this
approach has yet to be utilized in the context of developmental
programming. It must be noted however that in rodents the pro-
jections of neurons in the ARH to the paraventricular nucleus,
dorsomedial nuclei, and lateral hypothalamic area, areas that also
influence appetite regulation, develop postnatally and correspond
to a period of late gestation in the sheep and human (Muhlhausler
et al., 2008).
The use of a leptin antagonist in early life mimics the effects of
maternal caloric restriction. Attig et al. (2008a) administered a spe-
cific ObRb antagonist that blocked leptin’s action in the neonatal
rat, later predisposing offspring to leptin resistance and increased
body weight gain when fed a high energy diet postnatally. Fur-
ther work using leptin antagonists has shown that postnatal leptin
is necessary for maturation of numerous organs in the newborn
rat (Attig et al., 2011) with leptin antagonism resulting in aber-
rant pancreas, kidney, and ovarian development. We have shown
that administration of pegylated leptin antagonist (increased half
life compared to standard leptin antagonist) to rat neonates can
also modify their responsiveness to diet-induced obesity in adult
life but this is dependent upon prior maternal nutrition and
post-weaning diet (Beltrand et al., 2012).
Pregnancy is characterized by a state of leptin resistance com-
prising an adaptive response that facilitates maternal energy
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storage in preparation for the high metabolic demands of preg-
nancy and subsequent lactation (Ladyman et al., 2010). However,
despite resistance to the central anorectic effects of leptin, it has
also been reported that maternal leptin treatment to dams fed a
low protein diet can prevent the adverse metabolic programming
induced as a consequence of protein malnutrition (Stocker et al.,
2004). Increased exposure of the fetus to maternally derived gluco-
corticoids has been established as a mechanism regulating meta-
bolic demise in offspring; indeed leptin administration in models
of low maternal protein intake resulted in the normalization of
placental 11β-hydroxysteroid dehydrogenase-2 (11β-HSD2) lev-
els (Stocker et al., 2004), resulting in a potential reduction in fetal
exposure to maternal glucocorticoids. Of note, leptin administra-
tion to normally nourished dams also conferred protection against
diet-induced obesity in offspring (Stocker et al., 2007) suggesting
that effects may be independent of maternal dietary intake.
Maternal supplementation with methyl donors has also been
reported to modify some deleterious effects of programming on
offspring. Maternal folic acid supplementation in the rat follow-
ing protein restriction prevents epigenetic modification of hepatic
gene expression in the offspring including PPAR-α and -γ (Lilly-
crop et al., 2005). Whether the reversal of hypomethylation in this
setting improves metabolic outcome in offspring is not known. A
recent study using a similar model reported that maternal protein
and folic acid intake during gestation does not program leptin
transcription or circulating leptin concentrations in rat progeny
(Chmurzynska et al., 2011). Maternal glycine (Jackson et al., 2002)
and choline (Bai et al., 2012) supplementation can also prevent
MLP-induced hypertension in offspring in adulthood although
the mechanisms are not yet fully understood.
The role of catch-up growth on development of the adult obese
phenotype is still under debate. Work by Plagemann (2006) argued
that it may not be fetal undernutrition and low birth weight per se
that predisposes to adult-onset obesity; rather it is the overfeed-
ing of underweight newborns that may substantially contribute
to their long-term disease risk. When IUGR offspring are permit-
ted rapid catch-up growth by nutrient availability, these offspring
will demonstrate evidence of increase body weight and body fat,
and leptin resistance as adults. Conversely, if catch-up growth is
delayed by postnatal nutrient restriction, these offspring exhibit
normal body weight, body fat, and plasma leptin levels as adults
(Desai et al., 2005; Howie et al., 2011). However, in contrast to the
observations by Lopez et al. (2007) have reported that perinatal
overfeeding (using small litters, SL) does not induce alterations
in either the anorectic response to central leptin administration
or expression of leptin receptors and neuropeptides in adult rats.
The leptin resistance to peripheral leptin in adult SL rats may be
related to impaired leptin transport across the BBB. This trans-
port mechanism could be triglyceride-mediated as reported by
Banks et al. (2004). SL offspring have significantly elevated plasma
triglycerides as adults (Plagemann et al., 1999). As triglycerides
inhibit the transport of leptin across the BBB they could be a key
factor in the onset of the peripheral leptin resistance, which is a
hallmark of obesity.
Although leptin treatment has beneficial effects in ameliorating
metabolic disorders that result from developmental programming,
leptin treatment to offspring of normal pregnancies may have
adverse long-term metabolic effects which may relate to alterations
in the amplification and timing of the neonatal leptin surge (Itoh
et al., 2011). Itoh et al. (2011) showed that giving neonatal lep-
tin treatment to control mice lead to impaired glucose tolerance
in adult offspring. In the rat, the effects of exogenous leptin in
male offspring are directionally dependent upon maternal nutri-
tional status (Vickers et al., 2008). A study by Yura et al. (2005)
showed that treatment of male control offspring with leptin in
the neonatal period resulted in a modest increase in the risk for
obesity as compared to saline treated controls. This concurs with a
previous study of leptin given to normal neonatal rats which also
showed programmed hyperleptinemia and hyperinsulinemia in
adulthood, and lead to leptin resistance by reducing the expression
of the hypothalamic leptin receptor (Toste et al., 2006). However,
work by Pico et al. (2011) has shown that oral administration
of leptin at physiological doses to rat neonates had later positive
metabolic effects that prevented development of overweight and
obesity. Thus, studies in rodents suggest that early leptin treat-
ment may program either a later lean or obese phenotype. These
differences in metabolic outcomes across studies may relate in
part to the dosage used, source of leptin, gender, and method of
administration (Pico et al., 2011).
Interventional studies in humans demonstrate that leptin
administration in subjects with congenital complete leptin defi-
ciency or subjects with partial leptin deficiency (subjects with
lipoatrophy, congenital or related to HIV infection, and women
with hypothalamic amenorrhea) reverses the energy homeostasis
and neuroendocrine and metabolic abnormalities associated with
these conditions (Chan et al., 2011; Mantzoros et al., 2011). In con-
trast, leptin’s effects are largely absent in the obese hyperleptinemic
state, primarily as a result of leptin resistance or tolerance (Mant-
zoros et al., 2011). However, failure of leptin in the clinic as an
intervention in obesity, and withdrawal of numerous anti-obesity
drugs from clinical use, e.g., sibutramine, has stimulated new
approaches in the development of anti-obesity drugs. These efforts
are focused on utilizing leptin-related synthetic peptides as leptin
receptor antagonists or leptin-related synthetic peptide analogs or
mimetics (Grasso, 2011).
The current animal data fit with the PAR hypothesis proposed
by Gluckman and Hanson (2004a). Following the PAR hypothesis,
in response to a given in utero or early postnatal nutritional plane
(either high or low), cellular processes are invoked to cope with
the predicted environment. This hypothesis suggests that disease
only manifests when the actual nutritional environment diverges
from that which was predicted. Since the development of criti-
cal pathways involved in energy homeostasis in rodents continue
well into the postnatal period, it can be modified by both pre-
and postnatal environmental manipulation (e.g., prevention of
catch-up growth) and thus obesity can be potentiated, reversed, or
attenuated postnatally. It is likely that similar principles hold true
for humans although the timing of pathway development occurs
earlier than in rodents.
Work in the rodent has shown that treatment with both growth
hormone (GH) and insulin-like growth factor (IGF)-I can resolve
several aspects of the metabolic phenotype in developmentally
programmed offspring. In a model of maternal undernutrition
to induce fetal growth restriction, offspring fed either a control
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or high-fat diet postnatally demonstrated hypertension, obesity,
hyperphagia, hyperinsulinemia, and hyperleptinemia; the effects
of which were markedly amplified in the presence of a post-
natal high-fat diet (Vickers et al., 2000). Adult treatment with
GH normalized systolic blood pressure and reduced fat mass
but simultaneously exacerbated the hyperinsulinemia as a result
of the diabetogenic actions of GH (Vickers et al., 2002). IGF-
I infusion in adult females led to a complete normalization of
adiposity, appetite, fasting plasma insulin, and leptin concentra-
tions in developmentally programmed offspring (Vickers et al.,
2001). These studies highlight the role of the somatotropic axis
in metabolic disturbances although the longer term efficacy of
such treatment regimes is not known. Trials with GH in small
for gestation age children have shown a normalization in systolic
blood pressure which was maintained for the 6 year duration of
treatment (Holemans et al., 2004).
Epidemiological and experimental studies have shown that
early life adversity leads to glucose intolerance and an enhanced
risk for type 2 diabetes in offspring. Work by Simmons et al.
has shown that treatment of neonatal rats with the glucagon-like
peptide (GLP)-1 analog Exendin-4 (EX-4) reversed the adverse
consequences of being born growth restricted and prevented the
development of diabetes in adulthood (Stoffers et al., 2003; Park
et al., 2008; Raab et al., 2009). Neonatal EX-4 prevented the
progressive reduction in insulin-producing ß-cell mass that was
observed in IUGR rats over time and restored to normal levels
the expression of pancreatic duodenal homeobox (PDX), a criti-
cal regulator of pancreas development and islet differentiation. It
has recently also been shown that EX-4 increases histone acetylase
activity and reverses epigenetic modifications that silence PDX1 in
the intrauterine growth retarded rat (Pinney et al., 2011). Although
adiposity was not examined in this study, GLPs are known to
modify food intake, increase satiety, delay gastric emptying, and
suppress glucagon release and therefore further studies are needed
to explore these signaling pathways.
The role of possible direct nutritional interventions has been
highlighted in a study by Wyrwoll et al. (2006). Pregnant rats were
treated with synthetic glucocorticoids (Dexamethasone; DEX)
from embryonic day 13 to term; offspring were cross-fostered to
mothers on either a standard diet or a diet high in omega-3 fatty
acids, pups remained on these diets post-weaning. Maternal DEX
reduced birthweight and delayed the onset of puberty in offspring
and elicited hyperleptinemia and increased fat mass in offspring by
6 months of age. These effects were ameliorated by a high omega-
3 diet, demonstrating that direct manipulation of postnatal diet,
other than that associated with postnatal caloric restriction, can
limit adverse outcomes of maternal glucocorticoid administration.
The use of taurine supplementation either during pregnancy
and/or lactation has long been known to be efficacious in prevent-
ing pancreatic β-cell dysregulation and restoring normal prolifer-
ation and apoptosis of rat pancreatic islets following a MLP diet
(Boujendar et al., 2002). The mechanism by which taurine reg-
ulates the apoptotic rate of endocrine cells involving IGF-II and
Fas signaling pathways (Boujendar et al., 2002) are not completely
understood. Maternal LP diet leads to underexpression of VEGF
and Flk-1, associated with the lower fetal islet vascularization;
maternal supplementation with taurine prevented such damage
and may have a potential role in islet vasculogenesis (Boujendar
et al., 2003). Recent findings suggest that a maternal LP diet causes
long-lasting mitochondrial changes, which may contribute to the
development of type 2 diabetes later in life, and that a lack of
taurine may be a key causative factor for these dysfunctional mito-
chondrial changes (Lee et al., 2011); it may be through this route
that taurine serves also to regulate DNA synthesis.
PHYSICAL ACTIVITY AND EXERCISE AS AN INTERVENTION
Most of the investigations of developmental programming have
focused on metabolic and cardiovascular disorders and little atten-
tion has been paid to indices such as physical activity and effects
of exercise. The studies that have examined activity have primar-
ily focused on stress and anxiety behaviors, not direct physical
activity per se. Clinical and epidemiological studies of changes
in physical activity resulting from a poor fetal environment are
limited and it appears that two main factors have contributed to
this limitation: first, lifestyle influences obscure linkages between
metabolic predisposition and maturity onset behavioral patterns;
and second, the need to use subject diaries, that describe perceived
activity levels in clinical cohorts have inherent errors in the pre-
cision of reporting. Epidemiological studies of survivors of the
Dutch famine of 1944–1945 have shown that prenatal exposure
to famine resulted in not only altered food preferences toward
unhealthy diets but also showed trends toward reduced physical
activity in adulthood (Lussana et al., 2008).
A number of recent reports in animal models suggest that
several aspects of physical activity are determined by factors oper-
ating in early life. Studies in rats, using a variety of maternal
manipulations, have shown that voluntary locomotor behavior is
significantly reduced in offspring in postnatal life. Maternal under-
nutrition in the rat resulted in reduced physical activity before the
development of an obese phenotype with programming-induced
alterations in physical activity levels being reported as early as
postnatal day 35 (pubertal age; Vickers et al., 2003). Similarly, a
maternal LP diet has been shown to result in a significant reduc-
tion in voluntary locomotor activity in offspring (Bellinger et al.,
2006; Langley-Evans, 2007). The window of LP exposure is criti-
cal in determining effects on locomotor activity in offspring and
sometimes manifests in a gender-specific manner. In the mouse,
preconceptional LP feeding during one female ovulatory cycle
prior to natural mating led to a reduction in locomotor activ-
ity in offspring (Watkins et al., 2008). In the mouse, maternal
diet-induced obesity leads to a reduction in physical activity in
offspring (Samuelsson et al., 2008).
Despite growing evidence for the developmental programming
of sedentary behavior, little is known about the effect of exercise
as a maternal intervention. Any programming-induced compro-
mise in the control of resting metabolism, either through deficits
in oxidative fiber number or intramuscular energy sensing could
act as the initial trigger for increased susceptibility to developing
the metabolic syndrome (Nassis et al., 2005; Gardner and Rhodes,
2009). It has been suggested that as little as regular low-moderate
intensity exercise, independent of any reduction in bodyweight,
is needed to prevent the development of metabolic disorders in
offspring (e.g., via activation of muscle-specific PGC-1 for exam-
ple; Arany et al., 2007; Gardner and Rhodes, 2009). Using a rat
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model, Miles et al. (2009a) showed prenatally undernourished rats
increased their preference for wheel running versus lever press-
ing for food in a choice task. Further, despite a predisposition
to develop obesity under sedentary conditions, obesity develop-
ment was prevented in IUGR offspring when exercise was available
(Miles et al., 2009b).
ROLE OF EPIGENETICS
Epigenetics is the study of heritable changes in gene expression
or cellular phenotype caused by mechanisms other than changes
in the underlying DNA sequence (Henikoff and Matzke, 1997).
Because of their inherent malleability, epigenetic mechanisms are
susceptible to environmental influences and this environmental
susceptibility is expected to be enhanced during early develop-
ment. As such, this process is emerging as an important regulator
of the changes in gene expression undergone by adipose tissue dur-
ing obesity. Importantly, epigenetic marks may be reprogrammed
in response to both stochastic and environmental stimuli, such as
changes in diet and the in utero environment (Jaenisch and Bird,
2003).
Within tissues and organs that control metabolic homeostasis, a
range of phenotypes can be induced by sustained changes in mater-
nal diet via modulation of genes that control DNA methylation and
by histone acetylation, which suggests epigenetic programming
(Sebert et al., 2011). Leptin’s 3-kb promoter region is embed-
ded within a CpG island and contains many putative binding
sites for known transcription factors, such as Sp-1 sites, cAMP
response element, glucocorticoid response element, and a func-
tional CCAAT/enhancer binding protein (C/EBP-α) site which
contains a CG dinucleotide and is sufficient for tissue-specific gene
expression (Gong et al., 1996; Stoger, 2006). It has been shown that
leptin’s promoter is subject to epigenetic programming and leptin’s
expression can be modulated by DNA methylation.
Such potential mechanisms underlying epigenetic modification
of tissue function resulting in a predisposition to altered leptin and
insulin signaling are discussed by Holness and Sugden (2006). For
example, activation of the leptin receptor induced expression of
suppressor of cytokine signaling-3 (SOCS-3). This protein inhibits
leptin signal transduction and also potently inhibits insulin recep-
tor signaling. Altered SOCS-3 methylation may therefore have
lasting effects on the leptin-insulin feedback loop; the adipoinsu-
lar axis (Kieffer and Habener, 2000). Impaired glucose tolerance
during pregnancy is associated with altered leptin gene DNA
methylation with potential functional impacts (Bouchard et al.,
2010). In patients analyzed before and after bariatric surgery-
induced weight loss, a decrease in WAT leptin expression (about
50%) did not correspond to changes in promoter methylation
density. Thus, methylation density in the leptin promoter may
constitute one control level for cell-type specific leptin expression,
whereas weight loss induced changes in leptin expression does not
appear to be methylation-dependent (Marchi et al., 2011).
Fixed genomic variation explains only a small proportion of the
risk of adiposity. In animal models, maternal diet alters offspring
body composition, accompanied by epigenetic changes in meta-
bolic control genes. Little is known about whether such processes
operate in humans (Godfrey et al., 2011). Recent work has shown
the utility for perinatal epigenetic analysis in identifying individual
vulnerability to later obesity and metabolic disease (Godfrey et al.,
2011). In this study, epigenetic gene promoter methylation at birth
was associated with adiposity in children. Identification of in vivo
methylation of the leptin promoter provides a molecular entry
point to study the timing, factors, and conditions that lead to
tissue-specific methylation patterns of gene promoters (Stoger,
2006). Overall therefore, the application of epigenomic approaches
and the determination of targets (e.g., imprinted or non-imprinted
genes and methylation sites) for early life effects on epigenetic gene
regulation are exciting and important new areas of investigation
(McMillen and Robinson, 2005).
DISCUSSION
Numerous epidemiological studies have described a relation-
ship between an adverse prenatal environment and the devel-
opment of metabolic disease and obesity in later life. Both
clinical/epidemiological studies and experimental research have
clearly shown that the propensity to develop increased adipos-
ity in later life is increased when early life development has
been adversely affected. The pathogenesis is not based on genetic
defects but on altered genetic expression as a consequence of an
adaptation to environmental changes during early life develop-
ment. However, little is known about the interaction between
the pre-and postnatal nutritional environment on either ampli-
fication or resolution of the programming phenotype depend-
ing on the degree of nutritional match/mismatch. Thus, exper-
iments to examine the PARs hypothesis are required in con-
junction with transgenerational work to further the DOHaD
paradigm.
The molecular mechanisms underlying developmental pro-
gramming have only recently begun to be investigated. Epigenetics
has now become a mechanism that is fundamental to research
into DOHaD. The two most studied epigenetic mechanisms iden-
tified in the adaptive developmental programming of metabolic
disorders are DNA methylation and histone modifications. Avail-
ability of dietary methyl donors and cofactors during a critical
window of fetal development may influence DNA methylation pat-
terns. Thus, early methyl donor malnutrition (i.e., excess nutrition
or undernutrition) could effectively lead to premature epigenetic
aging (changes in age-associated DNA methylation patterns) and
thereby confer an enhanced susceptibility to adult disease in later
life (Waterland and Jirtle, 2004).
Developmental programming research offers a novel approach
to investigate the mechanistic basis of obesity and related meta-
bolic disorders which in human populations predominantly arises
from environmental factors and lifestyle choices. It is notable that
the variety of different insults in early life (caloric, protein, iron,
fat-fed) produce the same detrimental consequences in adult life,
suggestive of a common mechanism underlying the developmen-
tal early life programming of adult disease. An increasing number
of studies are now investigating avenues to reverse or ameliorate
the detrimental metabolic effects associated with developmental
programming. Of note, intervention studies with leptin in the
early period of developmental plasticity have shown promise in
reversing the programmed metabolic phenotype; however trans-
lation from small animal models to the human setting is difficult as
the critical windows observed in the rodent represent a late period
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of in utero development in larger species. However, the emerging
focus on studies aimed at reversing the programmed phenotype
offers an exciting potential for new advances in our understanding
of critical determinants and mechanisms for human obesity and
metabolic disorders.
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